The Ex-Pharma Exec Leading Trump's COVID-19 Vaccine Program Has $10 Million in Stock Options for a Company Getting Federal Funding
Read Full Article
- Dr Moncef Slaoui, a former pharma executive, was announced last week as a lead figure in President Donald Trump's push for a coronavirus vaccine.
- Slaoui resigned as a director of the company Moderna — which is trialing one vaccine — to take the position.
- However, he continues to hold stock options worth more than $10 million in Moderna, which has seen its stock price skyrocket in recent months...